ASL-话题@MedSci

#ASL#

165篇内容 | 3723人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1519239, encodeId=46e315192390c, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=2018 AASLD指南：肝细胞癌的治疗, objectType=article, longId=127572, objectId=509212e57202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=509212e57202, replyNumber=0, likeNumber=49, createdTime=2018-01-26, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=509212e57202, moduleTitle=2018 AASLD指南：肝细胞癌的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=509212e57202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519238, encodeId=63f9151923869, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=J HEPATOL:LI-RADS标准对小于3 cm的HCC的非侵入性诊断价值并不优于AASLD标准, objectType=article, longId=127513, objectId=dc2312e5139d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc2312e5139d, replyNumber=0, likeNumber=51, createdTime=2018-01-25, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc2312e5139d, moduleTitle=J HEPATOL:LI-RADS标准对小于3 cm的HCC的非侵入性诊断价值并不优于AASLD标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc2312e5139d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519237, encodeId=b842151923e6e, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=AASLD特约点评 | 赵明教授：Checkmate-040 研究——Nivolumab治疗晚期HCC的数据更新, objectType=article, longId=121557, objectId=f7f212155e0e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7f212155e0e, replyNumber=0, likeNumber=68, createdTime=2017-11-29, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7f212155e0e, moduleTitle=AASLD特约点评 | 赵明教授：Checkmate-040 研究——Nivolumab治疗晚期HCC的数据更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7f212155e0e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519236, encodeId=fbeb15192364e, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=AASLD2017 | 有TDF基线风险因素的慢乙肝初治患者应用TAF的疗效和安全性分析, objectType=article, longId=118039, objectId=ed9d11803991, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed9d11803991, replyNumber=0, likeNumber=62, createdTime=2017-10-31, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed9d11803991, moduleTitle=AASLD2017 | 有TDF基线风险因素的慢乙肝初治患者应用TAF的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed9d11803991)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519235, encodeId=5d3d151923508, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=AASLD2017 | 血清sPD-1水平可以预测慢乙肝的自发功能性治愈, objectType=article, longId=117952, objectId=e95211e95281, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e95211e95281, replyNumber=0, likeNumber=69, createdTime=2017-10-29, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e95211e95281, moduleTitle=AASLD2017 | 血清sPD-1水平可以预测慢乙肝的自发功能性治愈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e95211e95281)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519234, encodeId=0549151923423, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=AASLD2017 | 慢性乙肝女性产后肝炎发作的特征和预测因素, objectType=article, longId=117951, objectId=958c11e95192, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=958c11e95192, replyNumber=0, likeNumber=0, createdTime=2017-10-29, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=958c11e95192, moduleTitle=AASLD2017 | 慢性乙肝女性产后肝炎发作的特征和预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=958c11e95192)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519233, encodeId=692b151923364, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=AASLD2017：24-去甲熊去氧胆酸治疗非酒精性脂肪性肝病, objectType=article, longId=117772, objectId=daab11e7721f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=daab11e7721f, replyNumber=0, likeNumber=74, createdTime=2017-10-28, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=daab11e7721f, moduleTitle=AASLD2017：24-去甲熊去氧胆酸治疗非酒精性脂肪性肝病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=daab11e7721f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519232, encodeId=ce35151923225, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=Eur Radiol：也许是ASL又一里程碑的革新--自控超选择动脉自旋标记, objectType=article, longId=117623, objectId=75d111e623f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75d111e623f8, replyNumber=0, likeNumber=106, createdTime=2017-10-27, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75d111e623f8, moduleTitle=Eur Radiol：也许是ASL又一里程碑的革新--自控超选择动脉自旋标记, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75d111e623f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519231, encodeId=2a0e151923105, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=AASLD2017 | 多重耐药慢乙肝：只要替诺福韦就够了？, objectType=article, longId=117521, objectId=6e2c11e52130, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e2c11e52130, replyNumber=0, likeNumber=59, createdTime=2017-10-27, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e2c11e52130, moduleTitle=AASLD2017 | 多重耐药慢乙肝：只要替诺福韦就够了？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e2c11e52130)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519230, encodeId=0a41151923058, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=AASLD2017: 又双叒叕刷存在感! “神药”阿司匹林可降低肝癌风险, objectType=article, longId=117412, objectId=8fab11e41269, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fab11e41269, replyNumber=0, likeNumber=80, createdTime=2017-10-26, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fab11e41269, moduleTitle=AASLD2017: 又双叒叕刷存在感! “神药”阿司匹林可降低肝癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fab11e41269)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519229, encodeId=46951519229c5, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=AASLD2017 | 我国香港学者发现：慢乙肝口服选择性免疫调节剂安全有效, objectType=article, longId=117401, objectId=b62111e40187, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b62111e40187, replyNumber=0, likeNumber=100, createdTime=2017-10-26, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b62111e40187, moduleTitle=AASLD2017 | 我国香港学者发现：慢乙肝口服选择性免疫调节剂安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b62111e40187)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519228, encodeId=293e1519228c5, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=AASLD2017 | HVPG可以预测NASH代偿期肝硬化患者的临床疾病进展, objectType=article, longId=117397, objectId=012411e39769, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=012411e39769, replyNumber=0, likeNumber=51, createdTime=2017-10-26, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=012411e39769, moduleTitle=AASLD2017 | HVPG可以预测NASH代偿期肝硬化患者的临床疾病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=012411e39769)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519227, encodeId=adb0151922efc, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=AASLD 2017 | 范建高教授点评：HepQuant-STAT简易肝功能定量检测对NASH的无创诊断与评估, objectType=article, longId=117240, objectId=1f8211e24013, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f8211e24013, replyNumber=0, likeNumber=68, createdTime=2017-10-25, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f8211e24013, moduleTitle=AASLD 2017 | 范建高教授点评：HepQuant-STAT简易肝功能定量检测对NASH的无创诊断与评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f8211e24013)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519226, encodeId=4d91151922608, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=AASLD中国之声 | 聚焦多领域，多项成果在会上展示, objectType=article, longId=117233, objectId=835611e23349, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=835611e23349, replyNumber=0, likeNumber=68, createdTime=2017-10-25, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=835611e23349, moduleTitle=AASLD中国之声 | 聚焦多领域，多项成果在会上展示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=835611e23349)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519225, encodeId=2bf61519225cf, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=AASLD2017 | 荟萃分析：慢乙肝治疗24周时的HBsAg下降幅度可预测血清学清除, objectType=article, longId=117230, objectId=d4cf11e230a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4cf11e230a1, replyNumber=0, likeNumber=67, createdTime=2017-10-25, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4cf11e230a1, moduleTitle=AASLD2017 | 荟萃分析：慢乙肝治疗24周时的HBsAg下降幅度可预测血清学清除, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4cf11e230a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519224, encodeId=932815192243f, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=AASLD2017 | 乙肝免疫耐受期患者需要治疗吗？看看这项数据, objectType=article, longId=117196, objectId=a2d111e1963a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2d111e1963a, replyNumber=0, likeNumber=86, createdTime=2017-10-24, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2d111e1963a, moduleTitle=AASLD2017 | 乙肝免疫耐受期患者需要治疗吗？看看这项数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2d111e1963a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519223, encodeId=e54c151922394, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=AASLD2017 | 定量抗-HBc水平可预测慢乙肝停药后复发风险, objectType=article, longId=117193, objectId=e3fa11e1939d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3fa11e1939d, replyNumber=0, likeNumber=62, createdTime=2017-10-24, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3fa11e1939d, moduleTitle=AASLD2017 | 定量抗-HBc水平可预测慢乙肝停药后复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3fa11e1939d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519222, encodeId=93ae1519222a2, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=【IASLC WCLC 2017】听老周讲故事 | 当SCLC遇上免疫治疗, objectType=article, longId=116928, objectId=aa0611692863, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa0611692863, replyNumber=0, likeNumber=60, createdTime=2017-10-22, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa0611692863, moduleTitle=【IASLC WCLC 2017】听老周讲故事 | 当SCLC遇上免疫治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa0611692863)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519221, encodeId=fab0151922185, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=Radiology：利用MR AccASL技术评估Moyamoya病其显示远端脑动脉及侧枝循环的的价值, objectType=article, longId=114577, objectId=d2071145e7de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2071145e7de, replyNumber=0, likeNumber=91, createdTime=2017-09-29, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2071145e7de, moduleTitle=Radiology：利用MR AccASL技术评估Moyamoya病其显示远端脑动脉及侧枝循环的的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2071145e7de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1519220, encodeId=9ca115192204a, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, objectTitle=《2017年EASL临床实践指南：乙型肝炎病毒感染的管理》要点解读, objectType=article, longId=110398, objectId=dbd4110398bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbd4110398bc, replyNumber=0, likeNumber=37, createdTime=2017-08-23, rootId=0, userName=lq1771, userId=c1a311248160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbd4110398bc, moduleTitle=《2017年EASL临床实践指南：乙型肝炎病毒感染的管理》要点解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbd4110398bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASL

2020-05-29

lq1771 (审核中...)

前往app查看评论内容

#ASL#

2018 AASLD指南：肝细胞癌的治疗

2018-01-26

lq1771 (审核中...)

前往app查看评论内容

#ASL#

J HEPATOL:LI-RADS标准对小于3 cm的HCC的非侵入性诊断价值并不优于AASLD标准

2018-01-25

lq1771 (审核中...)

前往app查看评论内容

#ASL#

AASLD特约点评 | 赵明教授：Checkmate-040 研究——Nivolumab治疗晚期HCC的数据更新

2017-11-29

lq1771 (审核中...)

前往app查看评论内容

#ASL#

AASLD2017 | 有TDF基线风险因素的慢乙肝初治患者应用TAF的疗效和安全性分析

2017-10-31

lq1771 (审核中...)

前往app查看评论内容

#ASL#

AASLD2017 | 血清sPD-1水平可以预测慢乙肝的自发功能性治愈

2017-10-29

lq1771 (审核中...)

前往app查看评论内容

#ASL#

AASLD2017 | 慢性乙肝女性产后肝炎发作的特征和预测因素

2017-10-29

lq1771 (审核中...)

前往app查看评论内容

#ASL#

AASLD2017：24-去甲熊去氧胆酸治疗非酒精性脂肪性肝病

2017-10-28

lq1771 (审核中...)

前往app查看评论内容

#ASL#

Eur Radiol：也许是ASL又一里程碑的革新--自控超选择动脉自旋标记

2017-10-27

lq1771 (审核中...)

前往app查看评论内容

#ASL#

AASLD2017 | 多重耐药慢乙肝：只要替诺福韦就够了？

2017-10-27

lq1771 (审核中...)

前往app查看评论内容

#ASL#

AASLD2017: 又双叒叕刷存在感! “神药”阿司匹林可降低肝癌风险

2017-10-26

lq1771 (审核中...)

前往app查看评论内容

#ASL#

AASLD2017 | 我国香港学者发现：慢乙肝口服选择性免疫调节剂安全有效

2017-10-26

lq1771 (审核中...)

前往app查看评论内容

#ASL#

AASLD2017 | HVPG可以预测NASH代偿期肝硬化患者的临床疾病进展

2017-10-26

lq1771 (审核中...)

前往app查看评论内容

#ASL#

AASLD 2017 | 范建高教授点评：HepQuant-STAT简易肝功能定量检测对NASH的无创诊断与评估

2017-10-25

lq1771 (审核中...)

前往app查看评论内容

#ASL#

AASLD中国之声 | 聚焦多领域，多项成果在会上展示

2017-10-25

lq1771 (审核中...)

前往app查看评论内容

#ASL#

AASLD2017 | 荟萃分析：慢乙肝治疗24周时的HBsAg下降幅度可预测血清学清除

2017-10-25

lq1771 (审核中...)

前往app查看评论内容

#ASL#

AASLD2017 | 乙肝免疫耐受期患者需要治疗吗？看看这项数据

2017-10-24

lq1771 (审核中...)

前往app查看评论内容

#ASL#

AASLD2017 | 定量抗-HBc水平可预测慢乙肝停药后复发风险

2017-10-24

lq1771 (审核中...)

前往app查看评论内容

#ASL#

【IASLC WCLC 2017】听老周讲故事 | 当SCLC遇上免疫治疗

2017-10-22

lq1771 (审核中...)

前往app查看评论内容

#ASL#

Radiology：利用MR AccASL技术评估Moyamoya病其显示远端脑动脉及侧枝循环的的价值

2017-09-29

lq1771 (审核中...)

前往app查看评论内容

#ASL#

《2017年EASL临床实践指南：乙型肝炎病毒感染的管理》要点解读

2017-08-23

科室
- - 订阅+
  - 更多科室
工具
服务